These findings suggest that ATG4A expression is significantly altered in nasopharyngeal carcinoma, particularly in the presence of EBV, which may have implications for understanding the role of autophagy in tumor biology and potential therapeutic strategies. The gene discussed is ATG4A; the disease is nasopharyngeal carcinoma.